A molecular defect in virally transformed muscle cells that cannot cluster acetylcholine receptors by unknown
A Molecular Defect in Virally Transformed Muscle Cells 
that Cannot Cluster Acetylcholine Receptors 
Donna T. Anthony, Rae Janet Jacobs-Cohen,  Giovanna Marazzi, and Lee L. Rubin 
Laboratory of  Neurobiology, The Rockefeller University, New York, New York 10021-6399 
Abstract.  Muscle cells infected at the permissive tem- 
perature with temperature-sensitive mutants of Rous 
sarcoma virus and shifted to the non-permissive tem- 
perature form myotubes that are unable to cluster ace- 
tylcholine receptors  (Anthony, D.  T.,  S.  M.  Schuetze, 
and L.  L. Rubin.  1984.  Proc. Natl.  Acad. Sci. USA. 
81:2265-2269.).  Work described in this paper demon- 
strates that the vitally-infected cells are missing a 
37-kD peptide which reacts with an anti-tropomyosin 
antiserum. Using a  monoclonal antibody specific for 
the missing peptide,  we show that this tropomyosin 
is absent from fibroblasts and is distinct from smooth 
muscle tropomyosins. It is also different from the 
two previously identified striated muscle myofibrillar 
tropomyosins (alpha and beta).  We suggest that, in 
normal muscle, this novel, non-myofibrillar, tropo- 
myosin-like molecule is an important component of a 
cytoskeletal network necessary for cluster formation. 
characteristic feature of the vertebrate neuromuscular 
junction  is  its  enormously high  concentration of 
acetylcholine receptors (AChRs) I.  AChRs are uni- 
formly distributed along embryonic muscle fibers, but ac- 
cumulate at high concentrations at junctional sites in re- 
sponse  to  innervation.  This  accumulation  is  probably 
initiated by a factor of neural origin (12, 28, 43). In mature 
muscle, clusters are maintained by a component of the mus- 
cle's basal lamina, which has been studied in some detail (11, 
39).  How the muscle cell responds to molecules that induce 
clustering is not well understood, although it might be antici- 
pated that cytoskeletal elements are involved.  A variety of 
cytoskeletal molecules are present in either the postsynaptic 
region of adult muscle or beneath AChR clusters on cultured 
muscle cells. These include alpha-actinin, filamin, vinculin, 
talin, an intermediate filament-like molecule, nonmuscle ac- 
tin, a 300-kD protein, and a 58-kD protein (5-7,  19, 22, 23, 
33, 47, 49, 56; reviewed in reference 20). In addition, a 43- 
kD AChR-associated protein, thought to be capable of bind- 
ing to both the AChR (10) and actin (53), is concentrated near 
AChR clusters (8, 21, 42, 46, 50). 
The mere presence of a cytoskeletal molecule, however, 
does  not  guarantee  its  participation  in  clustering.  Other 
structural  changes occur during muscle cell development 
that could also require cytoskeletal reorganization. For in- 
stance, the synaptic region of muscle is characterized by ex- 
tensive membrane folds. In addition, we have shown that 
AChR clustering initiates the sub-membrane localization and 
immobilization of a set of myonuclei and Golgi apparatus. 
This process probably results from a cytoskeletal reorganiza- 
1. Abbreviations used in this paper: AChR, acetylcholine receptor; ALD, 
anterior latissimus dorsi;  HRP,  horseradish peroxidase;  PLD,  posterior 
latissimus dorsii; RSV, Rous sarcoma virus. 
tion beneath the  cluster  (17). To establish that particular 
cytoskeletal molecules have a direct role in clustering, evi- 
dence of a more functional nature must be obtained. 
Previously, we reported that chick myotubes that are in- 
fected at the permissive temperature  with a  temperature- 
sensitive mutant (tsNY68) of Rous sarcoma virus (RSV) and 
allowed to fuse at the nonpermissive temperature do not clus- 
ter their AChRs in response to a variety of factors that in- 
crease greatly the number of AChR clusters in normal muscle 
cells (3). This suggests that the transformed cells have a func- 
tional defect in clustering. We have tried to identify differ- 
ences between normal and transformed cells that might ac- 
count for this defect.  In this paper,  we demonstrate that 
transformed cells have greatly decreased levels  of a  non- 
myofibrillar protein that is labeled by an anti-tropomyosin 
antibody. This molecule could function in AChR clustering 
by stabilizing actin filaments. 
Materials and Methods 
Cell Culture 
Preparation of chick myotube cultures and viral infection were carried out 
as described previously (3), except that cultures were grown in 35-mm tis- 
sue culture dishes in DME (Gibco, Grand Island, NY) with 10% horse se- 
rum (Gibco) and 5 % chick embyro extract in an atmosphere containing 10% 
CO2. Rat muscle cell cultures were prepared as described previously, and 
cells were maintained in DME with 10% horse serum, 2% chick embryo 
extract, and 33 mM additional glucose (45).  For immunofluorescence ex- 
periments, cells were grown on acid-washed, collagen-coated glass cover- 
slips. 
One-dimensional SDS-PAGE 
Cultures were rinsed three times with ice-cold PBS and homogenized in 
SDS-PAGE sample buffer (5% SDS, 10% .glycerol, 62.5 mM Tris, pH 6.8, 
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until use. Protein was determined by the method of Schaffner and Weissman 
(48). One dimensional SDS-PAGE was performed according to the method 
of Laemmli (29). 
Western Blot Analysis 
Proteins resolved by SDS-PAGE were transferred to nitrocellulose by elec- 
troelution for 18-20 h at  150 mA constant current at room temperature in 
20 mM Tris-HCl, 150 mM glycine, 20% methanol (52). Gels and nitrocel- 
lulose sheets were pre-soaked in the transfer buffer for at least 20 min before 
electroelution. Proteins transferred to nitrocellulose were reversibly stained 
with 0.2%  Ponceau S (Serva Fine Biochemicals Inc., Garden City Park, 
NY) in 3%  trichloroacetic acid. 
Before antibody incubation, nitrocellulose blots were blocked with 10% 
horse or FCS (Gibco) in PBS for  1 h. The blots were incubated with the 
appropriate primary antibody overnight at 4°C or for 2 h at room tempera- 
ture in PBS containing 10% serum, 0.1% Triton X-100, 0.02% SDS (buffer 
A). They were then washed at room temperature three times for 10 min each 
in Buffer A minus serum. The appropriate second antibody-horseradish per- 
oxidase (HRP) conjugate (Hyclone Laboratories, Logan, UT) was diluted 
in Buffer A,  incubated with the blots at  room temperature for 2  h,  and 
washed as above. Blots were rinsed in water or 10 mM sodium citrate, pH 
4.5, and then reacted with 0.01% hydrogen peroxide and 0.5 mg/ml 4-chloro- 
i-naphthol in the citrate buffer (24, 30). The reaction was stopped by rinsing 
the blots in water. 
Monoclonal Antibodies 
To prepare antigen for immunization  of BALB/C mice, proteins from nonin- 
fected myotubes were resolved by SDS-PAGE,  and the gels were stained 
with Coomassie Blue. The 37-kD band which was found by Western blotting 
analysis to react with an anti-tropomyosin antibody (see Results) was ex- 
cised and washed in alternate lO-min cycles of I M ammonium  bicarbonate, 
pH 8.8, and water.  The gel slice was minced, and protein was extracted by 
overnight incubation in 1% SDS,  10 mM ammonium bicarbonate, pH 8.8, 
and I mM EDTA. About 50 lag protein was extracted into 1 ml of this buffer. 
Next, 0.5 ml of this solution was mixed with 0.5 ml AIu-GeI-S adjuvant 
(Serva) and injected into the peritoneum of mice at 5  w,  1.5 w, and 4  d 
before the tusion procedure. Mice were chosen ior fusions by bleeding from 
the orbital sinus and checking titers against low molecular mass tropomyo- 
sins on mini-Western blots. 
One day before the fusion, macrophage feeder layers were prepared (40). 
Fusion of spleen cells with NS-1 mouse myeloma cells was done using slight 
modifications (30) of standard procedures (40) with polyethylene glycol in 
75 mM Hepes buffer (Boehringer Mannheim, Indianapolis, IN). HAT se- 
lection was carried out according to standard protocols.  Hybridoma cells 
were grown in RPMI medium (Gibco) containing 10% FCS (Hyclone) and 
10 mM sodium pyruvate, and supernatants were assayed by mini-Western 
blots to detect wells that were producing antibodies predominantly against 
the desired molecular weight band. These cells were cloned in 0.5% Sea- 
plaque soft agar (FMC BioProducts, Rockland, ME) over feeder layers of 
rat embryo fibroblasts in the above medium. After ",,2 w, clones were picked 
and diluted into medium in 96-well microtiter plates. The supernatants were 
again analyzed by mini-Western blot analysis. 
Purification of  Smooth Muscle Tropomyosin 
Chicken gizzard tropomyosin was prepared by the method of Ebashi (16) 
modified by  Dr.  Fumio  Matsumum of Cold  Spring Harbor  Laboratory 
(Cold Spring Harbor,  NY)  (35).  Briefly,  100 gm frozen chicken gizzard 
(PeI-Freez Biologicals, Rogers, AK) was homogenized in 400 ml of a buffer 
containing 0.1  M  NaCI, 20 mM Tris, pH 7.4,  1 mM EDTA, and 5  mM 
2-mereaptoethanol, and centrifuged at 13,800 g for 20 min. The supernatant 
was saved, and the pellet was re-extracted and homogenized in  100 ml of 
the same buffer, but with 1 M  NaC1, and again centrifuged at 13,800 g for 
20 rain.  Both supernatants were heated separately at  100°C for  10 min, 
cooled on ice for 30 min and centrifuged as before. An additional 5  mM 
2-mercaptoethanol was added to each supernatant, which was subjected to 
28-36% ammonium sulfate fractionation. The pellets were redissolved to 
a final protein concentration of 5 mg/ml in 20 mM Tris, pH 7.4, containing 
5  mM 2-mercaptoethanol. 
Myofibril Preparation 
Chicken pectoral myofibrils were generously provided by Dr. Jim Dennis 
(Department of Anatomy and Cell  Biology, Cornell  University Medical 
College,  New  York,  NY).  Myofibrils  were  prepared  from  fascicles of 
anterior  latissimus dorsi  (ALD)  and  posterior  latissimus dorsi  (PLD), 
provided by Dr. Dennis, that had been stored at -20°C in buffer with 0.5% 
Triton X-100.  The fascicles were  minced into  1 mm pieces in K-Buffer, 
which consisted of 0.1  M  KCI,  10 mM sodium phosphate pH 7.0, 5 mM 
MgCIz,  1 mM EGTA,  1 mM dithiothreitol  (DTT), and 0.1  mM phenyl- 
methylsulfonyl fluoride (PMSF)  (Sigma Chemical Co.,  St.  Louis, MO). 
The mince was then homogenized before centrifugation at 3,000 rpm for 20 
min in a Sorvall SS-34 rotor.  The pellets were washed three times with 40 
ml of the same buffer and centrifuged as above. The final myofibril pellets 
were stored at -20°C in glycerol: buffer, 1:1. ALD and PLD muscle do not 
yield clean myofibrils because of the large amount of connective tissue in 
these muscles compared with that in pectoral muscle. 
Immunofluorescence 
Cultured Cells. Muscle cell cultures grown on glass coverslips were fixed 
at room temperature for 20 min in 3 % paraformaldehyde in PBS containing 
1 mM CaCI2 and 1 mM MgCI2, washed three times with PBS, permeabi- 
lized for 3 min in 0.1%  Triton in PBS, and again washed with PBS three 
times. Nonspecific binding sites were blocked in 10% horse serum in DME 
for 15 min at room temperature. Hybridoma supernatants or rabbit antisera 
diluted in  10%  horse serum were added to the coverslips for 30-60 min. 
The cells were washed three times with PBS, blocked for an additional 15 
min in  10%  horse serum in DME and then labeled with the appropriate 
FITC-conjugated  second  antibody  (Cooper  Biomedical,  Malvern,  PA; 
diluted 1:150 in 10% horse serum in PBS) for 30 min before washing three 
times in PBS, once in water and mounting with UV inert mountant (Atomer- 
gic Chemetals Corp., Farmingdale, NY). Photographs were taken using ap- 
propriate filter combinations for fluorescein and rhodamine on a Zeiss ICM 
405  microscope equipped with epifluorescence illumination (Carl  Zeiss, 
Inc., Thornwood, NY). 
Myofibrils 
Aliquots of the myofibril suspension were absorbed to gelatin-coated slides 
and incubated in 1% BSA in K-Buffer for 30 min to block nonspecific bind- 
ing sites. Antibodies diluted in 1% BSA in K-buffer were incubated with the 
tissue for 1 h. The slides were washed with K-buffer 3 times for 5 min each. 
The myofibrils were again incubated in 1% BSA in K-Buffer for 10 rain be- 
fore incubating them with the appropriate FITC-conjugated anti-mouse or 
anti-rabbit immunoglobulin (diluted 1:150 in 1% BSA in K buffer) for 30 
rain.  The slides were washed and rinsed as before and mounted in 90% 
glycerol in PBS. 
Results 
Indentification of  Myotube Troporayosin Isoforms 
Our interest  in muscle cells transformed  with temperature- 
sensitive mutants  of RSV arose from our observation that 
these  cells  are unable to cluster  AChRs even when main- 
tained  at  the  nonpermissive  temperature,  42°C  (3).  We, 
therefore,  compared these  cells  with  normal muscle cells 
grown at 42°C.  SDS-PAGE  revealed,  as anticipated,  that 
proteins of the two cell types were quite similar.  There were 
some differences, though. The most striking change was that 
one protein with an apparent molecular weight of 37 kD was 
virtually absent in infected myotubes that had been shifted 
to 42°C for 3-4 d (Fig.  1). This protein was also absent from 
cells shifted back to 37°C (data not shown).  It seemed un- 
likely that this difference between the two types of culture 
was due to vastly differing  numbers of myotubes. For all ex- 
periments, tsNY68-infected and uninfected cultures were in- 
spected to determine that comparable numbers of myotubes 
were present.  The numbers of cell  surface AChRs in both 
types of cultures  were also determined in some cases to en- 
sure that they were comparable (3). 
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acrylamide  gel  of total  protein  from  nonin- 
fected (lane 2) and tsNY68-infected (lane 1) 
muscle cell cultures grown at 42°C. The two 
types of cells are quite similar except that the 
infected cells are missing a peptide with an ap- 
parent molecular mass of 37 kD (arrow). Posi- 
tions of molecular mass standards are indicated 
on the left. 
The identity of the 37-kD peptide was suggested by experi- 
ments in which Western blots of equal amounts of total pro- 
tein from cultures of normal and transformed myotubes were 
probed  with  a  rabbit  polyclonal antibody,  TM#6  (kindly 
provided by  Dr.  Fumio Matsumura,  Cold  Spring  Harbor 
Laboratories), prepared against chicken gizzard tropomyo- 
sin  which  cross-reacts  with  many  tropomyosin  isoforms 
(35).  The  37-kD  peptide  in  normal  cells  is  labeled  with 
TM#6 (Fig.  2).  This immunoreactive peptide, however, is 
missing from tsNY68-infected myotubes kept at 42°C (Fig. 
2)  as  well  as  from those  shifted back to  37°C  (data  not 
shown). These experiments suggest that a molecule of 37 kD, 
which bears some structural similarity to a tropomyosin, is 
present in normal muscle cells, but absent from transformed 
ones. We will refer to this molecule as tropomyosin 2 since 
it is the peptide with the second highest molecular weight la- 
beled by the anti-tropomyosin antibody. 
Generation of  a Monoclonal Antibody Against 
Tropomyosin 2 
To characterize tropomyosin 2 more completely, we isolated 
it from SDS-gels prepared from cultures of normal chick 
myotubes. We immunized mice with the gel-eluted material 
for the production of monoclonal antibodies.  From one of 
our fusions, we obtained an antibody, D3-16, which preferen- 
tially labeled this peptide on Western blots of total muscle 
culture protein. In fact, D3-16 labeled this peptide strongly 
on Western blots more consistently than did TM#6 (see, for 
instance, Fig. 8). D3-16 also labeled a peptide with apparent 
molecular mass of 43 kD,  which was labeled by the anti- 
tropomyosin antibody TM#6, as well, and which will be re- 
Figure 2. Western blot of total protein from 
tsNY68-infected muscle cells  (lane 1)  and 
normal muscle cells (lane 2).  The blot was 
probed  with  TM#6  and  HRP-coupled goat 
ami-rabbit antibody. The main observation is 
that  the  37-kD peptide  (arrow) present  in 
noninfected muscle cells and absent from in- 
fected  muscle  cells  is  labeled  with  this 
antibody. 
ferred to as tropomyosin 1 (Fig. 4). Tropomysosin 1 was dis- 
tinct from alpha actin,  which was  not labeled by D3-16 in 
Western blots containing striated muscle myofibrillar  protein 
(Fig. 4, lane 1). Western blots using D3-16 showed clearly 
that tropomyosin 2 was greatly decreased in tsNY68-infected 
cells (Figs. 4 B and 8  C). 
Characterization of Tropomyosin 2 Expression 
Cellular Specificity.  We were interested in determining the 
cellular specificity of tropomyosin 2, its relationship to other 
muscle  tropomyosins,  and  its  distribution  within  muscle 
cells. To accomplish these goals, we used Western blotting 
and immunofluorescence techniques to compare the reactiv- 
ity of D3-16  with that of TM#6 and  with that of a  mouse 
monoclonal antibody, CH 1, that reacts only with alpha and 
beta skeletal tropomyosins (31; kindly provided by Dr. Jim 
J.-C.  Lin, Department of Biology, University of Iowa, Iowa 
City, IA). 
The first issue we addressed was whether tropomyosin 2 
truly was present only in normal striated muscle cells in cul- 
ture or whether it was additionally found in fibroblasts. This 
was important because even though both infected and nonin- 
fected myotube cultures were treated with cytosine arabino- 
side for 48 h to decrease the number of fibroblasts, tropo- 
myosins from residual fibroblasts might still have contributed 
to the many isoforms found in myotube cultures. In that case, 
the difference  between normal and transformed cultures in the 
level of tropomyosin 2 might have been due to differing num- 
bers  of  fibroblasts.  Fig.  3  is  a  representative  Coomassie 
Blue-stained  SDS-polyacrylamide gel  of total  cell  protein 
from fibroblast cultures (lane 2), tsNY68-infected myotubes 
(lane 3) and noninfected myotubes (lane 4), both grown at 
42°C.  Pectoral muscle myofibrils,  which contain alpha, but 
little beta, tropomyosin were included to mark the position of 
that peptide (lane 5). Alpha-actin is also a major component 
of the pectoral myofibrils.  Chicken gizzard tropomyosins at 
"~35 and 43 kD are also presented for comparison. As ex- 
pected, the cultured cell protein preparations contained nu- 
merous polypeptides and especially prominent actin bands. 
However, fibroblasts did not have either a major peptide that 
Figure 3. SDS-polyacrylamide 
gel  comparing  chicken  giz- 
zard  tropomyosins (lane  1), 
total  fibroblast protein  (lane 
2), total protein from tsNY68- 
infected muscle cells (lane 3), 
total protein from noninfected 
cultured muscle cells (lane 4), 
and pectoral myofibrils (lane 
5).  Tropomyosin 2  (arrow), 
prominent in cultured muscle 
cells,  is  markedly  decreased 
in the other preparations. Pec- 
toral myofibrils generally had 
small  amounts of the  37-kD 
peptide. Positions of molecu- 
lar  mass standards are  indi- 
cated on the left. 
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ity with TM#6 (A) and D3-16 (B).  Proteins 
from  pectoral  myofibrils (lane  1),  nonin- 
fected  muscle  cells  (lane  2),  tsNY68- 
infected muscle cells  (lane 3),  fibroblasts 
(lane 4), and chicken gizzard tropomyosins 
(lane 5) were first resolved by SDS-PAGE. 
TM#6  stains  most  tropomyosin  isoforms 
and shows the relative paucity of tropomyo- 
sin 2 in the other preparations.  D3-16 does 
not label fibroblast proteins or chicken giz- 
zard tropomyosins, but strongly reacts with 
tropomyosin  2.  D3-16 also  labels  weakly 
tropomyosin 2 in pectoral myofibrils. Posi- 
tions of tropomyosin  1,  which  also  reacts 
somewhat with D3-16, and of alpha (a) and 
beta (1~) tropomyosins are also given. Posi- 
tions of molecular mass standards are indi- 
cated on the left. 
Figure 5. Immunofluorescence  of uninfected chick myotubes labeled with TM#6 (A and D), CH 1 (B and E), and D3-16 (C and F). The 
top 3 micrographs  are fluorescent  images, and the bottom three are phase micrographs  of the same fields. Both TM#6 and CH  1 label 
myotubes in a striated fashion. TM#6 labels fibroblasts (F) as well. D3-16 labels myotubes uniformly and, like CH 1, does not label fibro- 
blasts.  Bar, 10 ~tM. 
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with tropomyosin 1 present in both noninfected and infected 
myotubes. 
A  Western blot prepared from a  similar gel is shown in 
Fig.  4.  The position of alpha-tropomyosin is  specified by 
TM#6 reactivity with pectoral myofibrils, and the position of 
tropomyosin 2 by D3-16 reactivity with cultured muscle. As 
judged by reactivity with both TM#6 and D3-16, it is clear 
that fibroblasts did not contain any immunoreactive tropo- 
myosin 2. They did contain, however, two tropomyosin iso- 
forms migrating just above and below the 43-kD myotube 
form, but these did not stain well with TM#6 and did not 
stain at all with D3-16 (Fig. 4). 
These results were consistent with those obtained from im- 
munofluorescence  studies.  Normal  myotubes  from  both 
chick and rat embryos stained diffusely with D3-16, but both 
types of fibroblast failed to stain  (Figs.  5  and 6).  Infected 
chick myotubes also did not stain (data not shown).  Taken 
together, these experiments suggest that the 37-kD  peptide 
missing  from tsNY68-infected muscle cell cultures is  not 
present in fibroblasts. This also demonstrates that differences 
between  normal  and  tsNY68-infected  myotube  cultures 
could not have been related to the presence of residual fibro- 
blasts in these cultures. 
We also compared myotube tropomyosins to those purifed 
from chicken gizzard.  The  major  tropomyosins  found in 
chicken gizzard had apparent molecular masses of 35 and 43 
kD, clearly different from that of tropomyosin 2 (Fig. 3, lane 
1 ). These peptides were labeled by TM#6 (Fig. 4 A, lane 5), 
but not by D3-16 (Fig. 4 B, lane 5). Thus, D3-16 recognizes 
an epitope that is not present in smooth muscle tropomyosins. 
Differences between Tropomyosin 2 and Myofibrillar 
Tropomyosins 
We were next interested in determining if tropomyosin 2  is 
one of the previously recognized striated muscle tropomyo- 
sin isoforms. Two forms of muscle tropomyosin have been 
well characterized. Myofibrillar beta tropomyosin has an ap- 
parent molecular mass of '~36 kD and is present in slow and 
Figure 6. Immunofluorescence  of rat myo- 
tube  culture  labeled  with  D3-16. Fluo- 
rescence (A)  and phase  (B)  images are 
shown. D3-16 labels these myotubes uni- 
formly, but again does not label fibroblasts 
that  are  present  throughout the culture. 
Bar, 10 IxM. 
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lar alpha tropomyosin has an apparent molecular mass of 34 
kD and is present in fast and slow muscle and in cultured 
myotubes. Montarras et al. (38) studied the expression of al- 
pha and beta tropomyosins in myotubes formed from myo- 
blasts transformed at 37°C with tsNY68 and shifted to 42°C. 
They found that expression of alpha-tropomyosin began soon 
after shift to the nonpermissive temperature, but that beta- 
tropomyosin expression did not peak until 48 h later.  West 
and Boettiger (54) reported that synthesis of alpha and beta 
tropomyosin in  RSV  tsLA24-infected myotubes decreased 
,o40% after a 29-h shift from nonpermissive to permissive 
temperatures. 
Experiments  with  pectoral  muscle  myofibrils  demon- 
strated, on the basis of molecular weights and reactivity with 
D3-16 (Figs. 3 and 4), that alpha tropomyosin and tropomyo- 
sin 2 are different. However, because of the similarity in mo- 
lecular weights between beta tropomyosin and tropomyosin 
2 and because of the previously reported effects of transfor- 
mation on muscle tropomyosin expression, it was important 
to determine whether the deficient 37-kD  polypeptide was 
beta tropomyosin. 
Comparisons between myofibrillar tropomyosins and tro- 
pomyosin 2 were again made by Western blot analysis and 
by immunofluorescence using the different antibodies. Myo- 
fibrils from ALD and PLD muscles and total protein from 
noninfected and  infected myotubes were first resolved by 
SDS-PAGE  and  stained  with  Coomassie  Blue  (Fig.  7). 
These preparations contained relatively high levels of con- 
taminating  proteins because  of the difficulty in  obtaining 
pure  myofibrillar  preparations  (compared  with  pectoral 
myofibrils, as seen in Fig. 3). Myofibrils from both PLD and 
ALD had major bands at 34 and 36 kD (lanes 1 and 2). In 
addition,  ALD  myofibrils had  a  band  at  ,o37  kD,  as  did 
noninfected cultured  muscle  cells.  The  37-kD  band  was 
clearly resolved from that migrating at 36 kD. Thus, on the 
basis of apparent molecular weights tropomyosin 2 is differ- 
ent from beta tropomyosin. 
The difference  between tropomyosin 2 and beta tropomyo- 
sin was confirmed by Western blotting of proteins prepared 
from similar SDS gels are presented in Fig. 8. The 34- and 
36-kD  bands  in  ALD,  PLD,  and  normal cultured muscle 
were labeled by both TM#6 (Fig. 8 A) and CH 1 (Fig. 8 B) 
and must, therefore, correspond to alpha and beta myofibril- 
lar  tropomyosin.  Staining  of beta  tropomyosin  appeared 
heavier in PLD than in ALD. CH 1 did not label tropomyosin 
2 in normal cultured muscle cells, though (Fig. 8 C). Fur- 
thermore, D3-16 did not label any proteins present in PLD 
myofibrils, although it lightly labeled a 37-kD band in some 
preparations of ALD myofibrils. 
Immunofluorescence of fixed and permeabilized cells also 
revealed differences in the staining patterns of the three anti- 
bodies and emphasized the difference between myofibrillar 
tropomyosins and  tropomyosin 2.  Both TM#6  and  CH  1 
stained cultured myotubes in a striated fashion. D3-16 stained 
chick  and  rat  myotubes  brightly,  but  uniformly  (Figs.  6 
and 7). 
Differences were also observed when the antibodies were 
used to label myofibrils isolated from ALD muscle, which 
contained both alpha and beta tropomyosins, or from pecto- 
ral muscle. TM#6 and CH 1 labeled the myofibrils in a stri- 
ated fashion. D3-16, on the other hand, labeled diffusely (in 
l~gure 7. Coomassie  Blue-stained 
SDS-polyacrylamide gel of pro- 
teins from PLD myoflbrils  (lane 
1),  ALD  myofibrils (lane 2), 
noninfected  cultured  muscle 
cells  (lane 3)  and  tsNY68-in- 
fected  muscle  cells  (lane 4). 
Tropomyosin 2 (arrow) is miss- 
ing from PLD myofibrils, but is 
present in ALD myofibrils. It is 
distinct from beta (13) and alpha 
(it)  tropomyosins  present  in 
both types of myofibrils. Posi- 
tions of molecular  mass stan- 
dards are given on the left. 
the case of ALD myofibrils) or not at all (Fig.  9).  These 
results strongly support the idea that tropomyosin 2  is not 
myofibrillar. 
Other Differences between Normal and 
Infected Muscle Cells 
On occasion, there were decreased amounts of beta tropo- 
myosin (Fig.  8 A,  lanes 2  and 3),  as observed previously 
(54),  as well as of tropomyosin 2,  in the infected muscle 
cells. In addition, tropomyosin 1 was sometimes present in 
increased amounts in the transformed cells (Fig.  8 A). CH 
1 labeling (Fig. 8 B) suggested that alpha tropomyosin may 
have been decreased in transformed cells also, but this was 
not observed consistently. Also, a peptide with the approxi- 
mate molecular mass of myosin was decreased in most ex- 
periments (Figs.  1 and 3). 
Discussion 
Absence of Tropomyosin 2 in Cells Unable 
to Cluster AChRs 
In a previous paper, we reported on properties of  chick skele- 
tal muscle cells infected with a temperature-sensitive mutant 
of RSV (3).  In those experiments, myoblasts were infected 
at the permissive temperature and were unable to fuse as long 
as they were kept at this temperature. When the cells were 
shifted to the nonpermissive temperature, they formed myo- 
tubes that were then unable to cluster AChRs, although they 
resembled normal cells in many other respects. Muscle cells 
infected with  tdl07A,  a  transformation-defective RSV  that 
lacks the src gene, were still able to cluster their AChRs. 
Thus,  we hypothesized that the presence of pp60  src some- 
how interfered with the clustering process. 
We have identified a  major deficit in the infected cells: 
greatly decreased amounts of a 37-kD protein that is labeled 
by a  polyclonal anti-tropomyosin antiserum.  Its reactivity 
The Journal of Cell Biology,  Volume 106, 1988  1718 Figure 8.  Western blots comparing reactivity with 
TM#6  (A),  CH  1 (B),  and  D3-16 (C).  Proteins 
from PLD  myofibrils (lane  1),  tsNY68-infected 
myotubes  (lane 2),  noninfected  cultured  muscle 
cells (lane 3) and ALD myofibrils (lane 4) were 
resolved by SDS-PAGE. As before, TM#6 stains 
several tropomyosin isoforms including  the pre- 
dominant alpha (a) and beta (13) forms in the myo- 
fibrils. In this figure, TM#6 does not label tropo- 
myosin 2 strongly.  CH 1 stains mainly alpha and 
beta  tropomyosins,  but  it  stains  alpha  more  in- 
tensely than  it  does  beta,  even though  both are 
present  in  roughly  equal  amounts  as judged  by 
Coomassie Blue  staining  (Fig.  7).  D3-16 labels 
tropomyosin 1 and tropomyosin 2 which is absent 
from PLD myofibrils, but present in small amounts 
in the ALD myofibril preparations (probably due 
to contamination with cytoplasmic or cytoskeletal 
material). Positions of molecular weight standards 
are given on the left. 
with this antiserum suggests that it is a tropomyosin isoform, 
and we have referred to it tentatively as tropomyosin 2. The 
resemblance  between  the  37-kD  peptide  and  the  class  of 
tropomyosins was further indicated by Western blot analysis 
of two-dimensional  gels using TM#6.  A  highly  acidic pro- 
tein, similar in isoelectric point to the tropomyosins, was ab- 
sent from lysates of the infected myotubes (data not shown). 
The possibility that tropomyosin 2 is a tropomyosin-like pro- 
tein  is  also  supported  by  the  observation  that  RSV-trans- 
formed fibroblasts  are known to be missing a  tropomyosin 
isoform (26, 27, 32, 34). That particular form, however, must 
be different from the one we have studied,  which is not pres- 
ent in fibroblasts. Amino acid analysis of the 37-kD peptide 
will  assist in confirming  its molecular identity. 
Figure 9.  Immunofluorescence of pectoral myofibrils stained with TM#6 (A and C) and D3-16 (B and D). Fluorescence (A and B) and 
phase (C and D) images of the same fields are given. TM#6 stains the myofibrils in an obviously striated fashion, but D3-16 stains the 
myofibrils weakly at best. Bar, 5  laM. 
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the amount of tropomyosin 2 in tsNY68-infected myotubes. 
The presence of pp60  ~r" in other kinds of infected cells is 
also known to affect synthesis of particular proteins. These 
include fibronectin (1), collagen isoforms (1, 15), caldesmon 
(41) and alpha-actin (55). As mentioned above, tropomyosin 
isoforms have also  been  shown  to change  in  transformed 
fibroblasts (see also reference 14). Thus, there is certainly 
precedent for the type of alteration we have observed. It is 
not clear how any of these effects are related to pp60~r~'s ac- 
tivity as a tyrosine protein kinase. 
We also do not know why the amounts of tropomyosin 2 
remain low even when the cells are maintained at the non- 
permissive temperature. In most cases, effects on particular 
proteins are  temperature-sensitive when cells are  infected 
with  ts-mutants.  It  is  possible  that,  in  our  experiments, 
pp60  ~r~ had an effect at the permissive temperature that was 
not  reversible  when  the  temperature  was  elevated.  This 
difference may reflect differences in the response to trans- 
formation between terminally differentiated nonreplicative 
cells, such as multinucleated muscle cells, and cells that re- 
main able to multiply. This idea is supported by the observa- 
tion of West  and Boettiger (54) that tsLA24-RSV infected 
myotubes maintained for several days at 42°C still lack well- 
developed  myofibrils.  In  our  experiments  as  well,  most 
noninfected  myotubes  were  elongated  and  striated,  with 
well-organized myofibrils and stress fibers. However, trans- 
formed myotubes seldom had striations and often appeared 
very broad and flattened. Also, Miskin et al.  (36) reported 
elevated  plasminogen  activator  levels  in  tsNY68-infected 
myotubes kept at 42°C  compared with  fibroblasts treated 
similarly. These results support the present observation that 
there are differences, even at 42°C, between normal and in- 
fected myotubes in the types or levels of proteins synthe- 
sized. 
Properties of Tropomyosin 2 
We used a monoclonal antibody generated against gel-eluted 
tropomyosin 2 to study its properties. In particular, tropo- 
myosin 2 was shown to be absent from rat and chick fibro- 
blasts and to be distinct from smooth muscle tropomyosins. 
Western blot analysis and immunocytochemical studies indi- 
cate that tropomyosin 2  is not predominantly myofibrillar. 
The small amount of labeling of ALD myofibrils probably 
reflects contamination from cytoplasmic or cytoskeletal tro- 
pomyosin 2. Our experiments distinguish especially between 
the 36-kD myofibrillar beta-tropomyosin recognized by TM#6 
and CH 1 antibodies and the 37-kD non-myofibrillar tropo- 
myosin 2 recognized by TM#6 and D3-16. 
If tropomyosin 2 is non-myofibrillar, what might its loca- 
tion be within muscle cells? Preliminary experiments involv- 
ing the immunoprecipitation of [32P]orthophosphate labeled 
infected and noninfected myotubes with TM#6 followed by 
SDS-PAGE and autoradiography revealed two phosphopro- 
teins from both infected and noninfected cells at 34 and 36 
kD  that did  not comigrate with  tropomyosin 2  (data  not 
shown). These are presumably alpha and beta tropomyosin, 
which are both known to be phosphorylated (37, 38).  This 
suggests that tropomyosin 2 resembles more closely the non- 
myofibrillar tropomyosins,  which  are  not  phosphorylated 
(25, 37). Thus, tropomyosin 2 may be a cytoskeletal molecule 
in muscle cells. 
Tropomyosin 2 May Function as Part of  a Sub-Cluster 
Cytoskeletal Network 
We and others have found the 43-kD AChR-associated pro- 
tein and a nonmuscle form of actin to be concentrated in the 
vicinity of AChR clusters and in the postsynaptic region of 
the adult  neuromuscular junction  (5,  8,  21,  42,  47).  Our 
previous work showed that the  initial  formation of AChR 
clusters, but not the integrity of existing clusters, is disrupted 
by cytochalasin treatment (17). One interpretation of these 
results is that an essential part of AChR clustering is the for- 
mation  of a  network  of actin  filaments  beneath  clusters, 
which  then  is  somehow  stabilized  against  disruption  by 
cytochalasins. In other cell types, tropomyosins are thought 
to form part of cytoskeletal networks, presumably by binding 
to actin filaments (14, 51). Under some circumstances, tropo- 
myosins also appear to stabilize actin networks (4, 18). Thus, 
it might well be that tropomyosin 2 is an important compo- 
nent of the muscle's cytoskeleton, binding to actin filaments 
forming beneath nascent clusters. The role of the 43-kD pro- 
tein would be to serve as a link between the AChR and actin. 
Evidence presented in this paper suggests that tropomyosin 
2  is present throughout embryonic muscle fibers grown in 
cell culture. Recently, we have found that tropomyosin 2 is 
enriched in junctional regions of adult rat intercostal fibers. 
This would be consistent with a crucial role in AChR cluster- 
ing. The presence of tropomyosin 2 in other regions of mus- 
cle  cells  may  indicate  that  it  is  also  involved  in  other 
processes  in  developing  muscle  that  are  dependent  on 
cytoskeletal organization, such as the formation of contrac- 
tile filaments (19), which, as was pointed out above, is defec- 
tive in the transformed cells. 
In conclusion, we have shown that RSV-infected muscle 
cells that are unable to cluster AChRs are missing a 37-kD 
peptide. The missing peptide is labeled by an anti-tropomyo- 
sin antibody and may prove to be a novel muscle cytoskeletal 
tropomyosin. Such a cytoskeletal component might mediate 
AChR clustering and may also play a role in other processes 
within muscle cells, such as the assembly of myofibrils. We 
are in the process of microinjecting our monoclonal anti- 
tropomyosin 2 antibody into normal myotubes to see if it has 
any effects on AChR clustering. We also intend to introduce 
tropomyosin 2 into tsNY68-infected myotubes to see if this 
allows them to cluster AChRs.  These types of experiment 
may give us a more direct indication of the role of tropomyo- 
sin 2 in AChR clustering. 
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